M Gertrude Gutierrez1, Noah Malmstadt. 1. Mork Family Department of Chemical Engineering and Materials Science, University of Southern California , 925 Bloom Walk, Los Angeles, California 90089, United States.
Abstract
We demonstrate successful incorporation of the G protein coupled receptor 5-HT1A into giant unilamellar vesicles using an agarose rehydration method. With direct observation using fluorescence techniques, we report preferential segregation of 5-HT1A into the cholesterol-poor liquid disordered phase of the membrane, contradicting previous reports of lipid raft segregation. Furthermore, altering the concentration of cholesterol and sphingomyelin in ternary mixtures does not alter 5-HT1A segregation into the liquid disordered phase.
We demonstrate successful incorporation of the G protein coupled receptor 5-HT1A into giant unilamellar vesicles using an agarose rehydration method. With direct observation using fluorescence techniques, we report preferential segregation of 5-HT1A into the cholesterol-poor liquid disordered phase of the membrane, contradicting previous reports of lipid raft segregation. Furthermore, altering the concentration of cholesterol and sphingomyelin in ternary mixtures does not alter 5-HT1A segregation into the liquid disordered phase.
G protein coupled receptors
(GPCRs) represent one of the largest families of proteins in the human
genome.[1] GPCRs mediate an extensive number
of extracellular signals pertinent to many physiological responses[2] via activation of secondary messengers within
the cell.[3] GPCRs are integral membrane
proteins containing seven transmembrane helices. They are coupled
via their cytoplasmic domains to heterotrimetric G proteins
that shift between a guanosine triphosphate-bound state
that induces intracellular downstream activity and an inactive guanosine
diphosphate-bound state.[4]The 5-hydroxytryptamine
receptor subtype 1A (5-HT1A)
is a GPCR that is found throughout the central nervous system.[5] It binds the neurotransmitter serotonin
(i.e., 5-hydroxytryptamine), which regulates mood, responses
to stress, and emotion.[6] GPCRs in general
and 5-HT1A in particular have been reported to partition
into lipid rafts in mammalian cell plasma membranes.[7] Such rafts are suggested to be areas in the plasma membrane
where sphingolipids, cholesterol, and proteins congregate. These
raft domains have been suggested to play important roles in cell sorting
and signaling.[8,9] It has been reported that mast
cells[10] and T-cells[11] reduce their signaling activity when cholesterol is depleted,
therefore suggesting that cellular lipid rafts facilitate signaling
pathways. In 2009, Singh and Chattopadhyay reported that after treatment
with sphingomyelinase, 5-HT1A displays a loss of
agonist binding, suggesting a necessity for raft segregation for functionality.[12]Detergent-resistant membrane (DRM) fragment
separation is the traditional
biochemical method used to determine the partitioning of proteins
into lipid rafts.[13] DRM studies report
that 5-HT1A is found in the cholesterol-rich layer of DRM
separations, thus suggesting liquid ordered phase preference in mammalian
cells.[14,15] Direct visualization of raft domains in
mammalian cells, however, has been elusive.[16] Furthermore, while DRMs have been heavily used to associate proteins
to lipid rafts, in 2005, Lichtenberg et al. reported that DRMs should
not implicate lipid raft association due to congregating forces in
the centrifugation process.[17] Liquid ordered
and liquid disordered phase separation in model membranes is a prominent
biomimetic platform for the assessment of lipid phase behavior which
avoids artifacts like those associated with DRM fragment preparation.[18−20]Phase separation in model membranes has been extensively observed,[21] though visualization of protein segregation
into either of the phases has posed a challenge due to synthetic membrane
fabrication processes. Incorporation of proteins into giant unilamellar
vesicles (GUVs) is incompatible with traditional methods of fabrication,
namely, electroformation and gentle hydration.[22,23] Less protein-disruptive methods of vesicle formation have been reported
recently. Hydration methods utilizing both agarose[24] and cross-linked dextran[25] have
been developed, and we have previously reported successful incorporation
of proteins into GUVs using an agarose swelling method.[26]While 5-HT1A has been incorporated
into the membranes
of nanoscale liposomes, this membrane format is inaccessible to fluorescent
microscopy, making observations of phase segregation impossible. Giant
unilamellar vesicles (10–100 μm in diameter) are more
suitable for direct observations. In 2013, Kang et al. reported an
application of hydrogel stamping followed by electroformation for
GUV fabrication.[27] They were able to incorporate
membrane fragments containing human acetylcholine receptor into GUVs.
While the presence of protein was detected via antibody binding, phase
segregation behavior was not reported.[27] Furthermore, May et al. in 2013 reported the insertion of in vitro expressed dopamine receptor D2 (DRD2) into polymersome
membranes. While antibody and ligand binding was reported, the fabricated
polymersomes were 100 nm in diameter,[28] were inaccessible to fluorescence microscopy, and deviated from
the lipid cellular environment in which DRD2 is naturally found.Here, we present for the first time the direct incorporation of
5-HT1A into GUVs and observe 5-HT1A in phase
separated vesicles. Through fabrication of GUVs containing 5-HT1A membrane fragments, we are able to confirm the protein’s
incorporation and identify its location in the membrane through primary
antibody labeling and ligand binding. We observe that 5-HT1A preferentially segregates into the cholesterol-poor liquid disordered
region. Furthermore, varying concentrations of cholesterol and brain
sphingomyelin in the membrane do not affect the partitioning
of 5-HT1A.GUVs were made of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC), cholesterol (Chol), and brain sphingomyelin (BSM)—a
simple tertiary mixture known to phase-separate at certain compositions
and temperatures.[19] POPC is found in the
outer leaflet of the plasma membrane[29] and
is a major component of lipids extracted from biological sources.[30] Previous reports suggest that functionality
of 5-HT1A is dependent on sphingomyelin.[12,31] To test the role of sphingomyelin in GPCR phase behavior,
GUVs made from varying concentrations of BSM together with 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), and Chol were
also investigated. The DOPC/DPPC-based system has been shown to separate
into micrometer-scale liquid domains over a wide range of temperatures
and is not subject to photooxidation-based artifacts that have
been noted in POPC-based systems.[19,32,33]Lipid bilayers were labeled with the fluorescent
lipidATTO-488-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
(ATTO-488-DPPE),
and vesicles were fabricated using the protein incorporation hydration
method reported by Hansen et al. in 2013.[24] GUVs were swollen from a lipid film cast over a thin layer of agarose
in which 5-HT1A membrane fragments had been dissolved (Figure S1). Protein-free control GUVs were fabricated
by omitting the membrane fragments from the agarose. For the assessment
of antibody binding, samples were incubated at physiological temperature
(37 °C) with 5-HT1A antibodies labeled with rhodamine
for 1 h. To confirm the proper folding of the protein, a fluorescent
antagonist, a NAN-190 derivative, was used in a binding assay. Samples
were exposed to 1 mM of the antagonist at 37 °C for 10 min.[34] Observation chambers were washed with 200 mM
glucose in PBS (pH 7.4) to remove excess antibody or ligand. During
observation GUVs were held at 30 °C to achieve microscale phase
separation.[19] Fluorescence imaging was
performed using spinning-disk confocal microscopy and images presented
are standard deviation Z-stack projections unless otherwise stated.Phase
separating vesicles with and without 5HT-1A incorporated.
Lipid label fluorescence is on the left; 5HT-1A antibody
fluorescence is on the right. (A) Phase separation observed on GUVs
(1:1:3 POPC:Chol:BSM) without protein and incubated with antibody
for 1 h. No signal is detected at 561 nm indicating that antibody
does not bind to the lipid membrane. (B) Protein-incorporated GUV
1:1:3 POPC:Chol:BSM displaying phase separation prior to antibody
binding (confocal slice). (C) GUV 1:1:3 POPC:Chol:BSM displaying phase
separation after 1 h incubation with antibody. Signals from 491 and
561 nm excitation indicate successful specific binding of antibody
to 5-HT1A. All scale bars are 5 μm.Figure 1A shows a GUV without
protein after
incubation with labeled antibody; no antibody is seen to associate
with the membrane. In 5-HT1A-incorporated GUVs, antibody
fluorescence can be seen to accumulate on the outer GUV surface during
incubation (Figures S2 and S3). Figure 1B shows a protein-incorporated, phase-separated
GUV prior to antibody incubation. After protein-containing GUVs were
exposed to antibody for 1 h, binding of the labeled antibody to 5-HT1A is clearly observed (Figure 1C).
The protein co-segregates with the ATTO-488 fluorescent lipid tag.
Figure 1
Phase
separating vesicles with and without 5HT-1A incorporated.
Lipid label fluorescence is on the left; 5HT-1A antibody
fluorescence is on the right. (A) Phase separation observed on GUVs
(1:1:3 POPC:Chol:BSM) without protein and incubated with antibody
for 1 h. No signal is detected at 561 nm indicating that antibody
does not bind to the lipid membrane. (B) Protein-incorporated GUV
1:1:3 POPC:Chol:BSM displaying phase separation prior to antibody
binding (confocal slice). (C) GUV 1:1:3 POPC:Chol:BSM displaying phase
separation after 1 h incubation with antibody. Signals from 491 and
561 nm excitation indicate successful specific binding of antibody
to 5-HT1A. All scale bars are 5 μm.
Partitioning of ATTO-488-DPPE into the liquid disordered phase
was confirmed by measuring domain size as a function of composition—dark
domains occupy less vesicle surface area as the concentration of ordered
phase-preferring lipids (BSM and Chol) is decreased (Figure S4). These dark regions can be identified as liquid
ordered based on previous work showing that this lipid system exhibits
liquid–liquid coexistence at the temperatures studied here.[35] Further, the ATTO-488-DPPE segregates in a manner
identical to that of rhodamine-labeled DPPE, which has been previously
shown to segregate preferentially to liquid disordered domains (Figure S5).[36]5-HT1A segregates to the liquid disordered phase over
a range of compositions spanning the immiscible region of the POPC:Chol:BSM
phase diagram. Figure 2A shows two compositions
of POPC:Chol:BSM (1:1:3 and 2:1:2) yielding phase-separated GUVs with
protein incorporated following antibody binding. 5-HT1A preferentially segregates into liquid disordered phase regardless
of sphingomyelin concentration, contradicting previous DRM-based
reports.[14,15] This preference for the disordered phase
remains the case as Chol concentration is varied across the immiscible
region of the phase diagram (Figure S6).
Figure 2
Antibody labeling and ligand binding results
on protein incorporated
GUVs at varying lipid compositions. (A) GUVs showing protein phase
segregation via antibody binding. Excitations at 491 nm (left) and
561 nm (middle) are overlaid in the right image. Top is 1:1:3 and
bottom is 2:1:2 POPC:Chol:BSM. This shows preferential segregation
of 5-HT1A in the liquid disordered (bright) phase. (B)
GUVs at 491 nm (left) and 640 nm (middle) excitation show 5-HT1A segregation into the liquid disordered phase after successful
antagonist binding. Top is 1:1:3 and bottom is 2:1:2 POPC:Chol:BSM.
Protein preferentially segregates to liquid disordered phase. All
scale bars are 5 μm.
We used a fluorescent antagonist to identify 5-HT1A ligand
binding on GUVs. The ligand only associates to GUVs when protein is
present (negative control in Figure S7),
indicating that the protein is properly folded with an available binding
site. Furthermore, as shown in Figure 2B, overlap
of fluorescence from the lipid and the ligand is observed, indicating
that upon binding of the antagonist, 5-HT1A remains in
the liquid disordered phase.Antibody labeling and ligand binding results
on protein incorporated
GUVs at varying lipid compositions. (A) GUVs showing protein phase
segregation via antibody binding. Excitations at 491 nm (left) and
561 nm (middle) are overlaid in the right image. Top is 1:1:3 and
bottom is 2:1:2 POPC:Chol:BSM. This shows preferential segregation
of 5-HT1A in the liquid disordered (bright) phase. (B)
GUVs at 491 nm (left) and 640 nm (middle) excitation show 5-HT1A segregation into the liquid disordered phase after successful
antagonist binding. Top is 1:1:3 and bottom is 2:1:2 POPC:Chol:BSM.
Protein preferentially segregates to liquid disordered phase. All
scale bars are 5 μm.To further understand the role of sphingomyelin on
the phase
separation of 5-HT1A in GUVs, we prepared phase- separated
GUVs in which BSM was replaced in part or completely with DPPC. Replacing
POPC with DOPC in this system facilitates phase separation with DPPC
(which we used as a saturated lipid to substitute for BSM) and eliminates
potential photooxidation artifacts. Ternary compositions of 3:2:5
DOPC:Chol:DPPC and 3:2:5 DOPC:Chol:BSM and a quaternary composition
of 3:2:2.5:2.5 DOPC:Chol:DPPC:BSM were investigated (Figure 3). In all compositions, 5-HT1A is observed
to partition into the liquid disordered phase suggesting that sphingomyelin
has no particular effect on partitioning.
Figure 3
Results from varying BSM ratios in synthetic
vesicles, showing
no effect on preferential liquid disordered phase segregation of 5-HT1A: (A) 3:2:5 DOPC:Chol:DPPC, (B) 3:2:5 DOPC:Chol:BSM, and
(C) 3:2:2.5:2.5 DOPC:Chol:DPPC:BSM. All images show phase separation
at 491 nm (left) and 561 nm (middle) excitation. 5-HT1A segregates into the liquid disordered phase regardless of sphingomyelin
concentration. All scale bars are 5 μm.
The membrane fragment-incorporated
GUVs that we demonstrate here
allow for the first direct observation of the phase behavior of GPCRs
in model membranes. Our observations contradict conclusions from DRM-based
studies and show that 5-HT1A resides in the liquid disordered
phase of membranes. Sphingomyelin does not have an effect on the preferential
segregation of 5-HT1A. This work provides a foundation
for further investigations to characterize GPCRs through microscopic
observation of model membranes.Results from varying BSM ratios in synthetic
vesicles, showing
no effect on preferential liquid disordered phase segregation of 5-HT1A: (A) 3:2:5 DOPC:Chol:DPPC, (B) 3:2:5 DOPC:Chol:BSM, and
(C) 3:2:2.5:2.5 DOPC:Chol:DPPC:BSM. All images show phase separation
at 491 nm (left) and 561 nm (middle) excitation. 5-HT1A segregates into the liquid disordered phase regardless of sphingomyelin
concentration. All scale bars are 5 μm.
Authors: Mayako Michino; Enrique Abola; Charles L Brooks; J Scott Dixon; John Moult; Raymond C Stevens Journal: Nat Rev Drug Discov Date: 2009-06 Impact factor: 84.694
Authors: Nestor Lopez Mora; Yue Gao; M Gertrude Gutierrez; Justin Peruzzi; Ivan Bakker; Ruud J R W Peters; Bianka Siewert; Sylvestre Bonnet; Roxanne E Kieltyka; Jan C M van Hest; Noah Malmstadt; Alexander Kros Journal: Soft Matter Date: 2017-08-23 Impact factor: 3.679
Authors: Jesper S Hansen; Karin Elbing; James R Thompson; Noah Malmstadt; Karin Lindkvist-Petersson Journal: Chem Commun (Camb) Date: 2015-02-11 Impact factor: 6.222
Authors: M Gertrude Gutierrez; Jacob Deyell; Kate L White; Lucia C Dalle Ore; Vadim Cherezov; Raymond C Stevens; Noah Malmstadt Journal: Chem Commun (Camb) Date: 2019-05-14 Impact factor: 6.222
Authors: Kim S Horger; Haiyan Liu; Divya K Rao; Suneet Shukla; David Sept; Suresh V Ambudkar; Michael Mayer Journal: Biochim Biophys Acta Date: 2014-11-04
Authors: M Gertrude Gutierrez; Farzad Jalali-Yazdi; Justin Peruzzi; Carson T Riche; Richard W Roberts; Noah Malmstadt Journal: Small Date: 2016-08-16 Impact factor: 13.281